AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI Lung Cancer Devices Show Wide Performance Gaps as Real-World Variation Bites
AuntMinnie reports that AI devices for lung cancer detection vary widely in performance, highlighting a persistent gap between promising demos and clinical reliability. The findings reinforce how sensitive these tools are to data quality, acquisition protocols, and deployment setting.
FDA Guidance Changes Put Medtech AI Teams on Notice
A new industry analysis says FDA’s AI device guidance is evolving in ways that will force medtech companies to tighten documentation, monitoring, and change management. The underlying message is clear: AI products will be judged less like static tools and more like living systems.
FDA Rejects Partial 510(k) Exemption for Some AI Devices, Keeping the Bar High
The FDA has declined to create a partial 510(k) exemption for certain AI-enabled medical devices, signaling that regulators are not ready to loosen premarket oversight for software with clinical impact. The decision is a reminder that even as AI becomes more embedded in care delivery, U.S. device policy is still anchored in risk, traceability, and validation.
FDA Rejects Industry Push to Loosen Oversight of Some AI Devices
The FDA has reportedly turned down an industry proposal that would have eased regulation for certain AI-enabled medical devices, signaling the agency is not ready to treat software risk as inherently lower simply because it can be updated quickly. The decision reinforces a more cautious regulatory posture just as manufacturers are pressing for faster pathways for iterative AI products.
FDA and UK Strengthen MedTech Regulatory Partnership as Global Harmonization Gains Pace
The UK and US are deepening cooperation on medical technology regulation, a move that could make it easier for device makers to navigate approvals across major markets. The development reflects a broader push toward regulatory alignment in an industry increasingly shaped by software and cross-border evidence generation.
AI smart glasses for macular degeneration show healthcare AI’s quieter consumer-device frontier
Eyedaptic’s latest AI-based smart glasses for age-related macular degeneration highlight a less-discussed edge of healthcare AI: assistive consumer devices. Unlike diagnostic AI, this market competes on usability, everyday benefit, and sustained adoption more than on regulatory novelty alone.
Digital pathology AI review highlights a field advancing faster than its evidence standards
A medRxiv review of AI devices for image analysis in digital pathology points to rapid technical progress in one of medicine’s most data-rich specialties. It also reinforces a familiar concern: deployment pressure is rising faster than consensus on validation, comparability, and real-world utility.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.